awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26827319-0E9A152F-FA59-4F1C-BDF2-54C37CD8BE31
Q26827319-0E9A152F-FA59-4F1C-BDF2-54C37CD8BE31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827319-0E9A152F-FA59-4F1C-BDF2-54C37CD8BE31
Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma
P2860
Q26827319-0E9A152F-FA59-4F1C-BDF2-54C37CD8BE31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827319-0E9A152F-FA59-4F1C-BDF2-54C37CD8BE31
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f84e3244d92ba8759d2d838bc2df32ab48f75f2b
P2860
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.